DAB.bio
PrivateLast Round
Seed
Oct 28, 2025
Total Funding Raised
$2.58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DAB.bio operates in Healthcare & Life Sciences and is based in Delft. Its latest recorded funding round was a Seed round in October 2025.
DAB.bio is an industrial biotechnology company that develops and licenses advanced fermentation technology to enable cost-competitive, large-scale production of bio-based chemicals, fuels, and proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Clean Manufacturing, Alternative Fuels
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DAB.bio Comparables
Compare DAB.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pow.Bio | 79% | |
| Cauldron | 77% | |
| Planetary | 77% |
For institutional investors. Book with your work email.
DAB.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 28, 2025 | ||||
| Grant | Dec 1, 2021 | ||||
| Seed | Jul 1, 2021 | ||||
| Series A | Apr 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DAB.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Navus Ventures | Seed |
| Mibiton Foundation | Grant |
| Capricorn Partners | Seed |
| Invest-NL | Seed |
| FORWARD.one | Seed, Series A |
| Delft Enterprises | Series A |
| InnovationQuarter | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 45% MoM.
- Mar 5, 2026
Monthly visitors increased 144% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
DAB.bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DAB.bio's valuation, stock price, and market status.
Is DAB.bio a public or private company?
DAB.bio is a private company.
What is the current stock price of DAB.bio?
DAB.bio is a private company, so its shares have no public market price. Caplight tracks DAB.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DAB.bio worth (valuation)?
Valuation information for DAB.bio is not publicly available.
Can I buy DAB.bio stock?
DAB.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DAB.bio's last funding round?
DAB.bio's most recent funding round was Seed on October 28, 2025.
Who are the main investors in DAB.bio?
Key investors in DAB.bio include Navus Ventures.
Will DAB.bio IPO soon?
No public IPO plans have been announced for DAB.bio.
How can I track DAB.bio secondary market activity?
Caplight tracks bids, offers, and trades in DAB.bio's shares on secondary markets.